New York, NY – July 6, 2016 – Dr. Gregg Stone, CRF’s Co-Director of Medical Research and Education, was quoted in articles from the Associated Press and Wall Street Journal on the FDA approval of a new stent which is designed to completely dissolve within three years. The stent was approved for use in patients with coronary artery disease, a condition which causes about 370,000 deaths each year in the U.S. Dr. Stone was chairman of the clinical trial program which studied the new device.  

Press Contacts

Irma Damhuis
Director, External Relations
Tel: 646-434-4690

Judy Romero
Program Manager, External Relations
Tel: 646-434-4608

Eucomed Guidelines go into effect
1 January 2018, update your TCTMD profile to be eligible for Grant Support to attend CRF meetings including TCT! https://www.tctmd.com/